Compliance & Medical Disclaimer
This article is for informational and educational purposes only and does not constitute medical, legal, regulatory, or professional advice. The compounds discussed are research chemicals not approved for human consumption by the US FDA, European Medicines Agency (EMA), UK MHRA, Australian TGA, Health Canada, or any other major regulatory authority. They are sold strictly for laboratory research use. WolveStack does not employ medical staff, does not diagnose, treat, or prescribe, and makes no health claims under FTC, UK ASA, EU MDR/UCPD, or AU TGA standards. Always consult a licensed healthcare professional in your jurisdiction before considering any peptide protocol. This site contains affiliate links (FTC 2023 endorsement guidelines compliant); we may earn a commission on qualifying purchases at no additional cost to you. Some compounds discussed are on the WADA prohibited list — competitive athletes should verify current status with their governing body before any research use. Use of research chemicals may be illegal in your jurisdiction.
IMPORTANT: This compound is currently on the World Anti-Doping Agency (WADA) prohibited list. Competitive athletes face sanctions for use including in retirement testing programs. Verify current WADA status with your sport's governing body before any research involvement.
Editorial policy
Editorial review process: WolveStack Research Team — collective expertise in peptide pharmacology, regulatory science, and research literature analysis. We synthesize peer-reviewed studies, regulatory filings, and clinical trial data; we do not provide medical advice or treatment recommendations. Content is reviewed and updated as new evidence emerges.
Medical Disclaimer
For informational and educational purposes only. Not FDA-approved for human use. Consult a licensed healthcare professional. See full disclaimer.
CJC-1295 safety: generally well-tolerated at therapeutic doses (100-200 mcg 2-3x weekly). Common side effects: transient headache (10%), mild water retention (15%), increased appetite (20%), injection site irritation (5%). Serious adverse effects rare. Contraindications: active cancer, uncontrolled diabetes, untreated sleep apnea. Long-term safety data absent; cycling recommended. Monitoring: baseline and annual blood work if using chronically.
Documented Adverse Effects
Comprehensive information about documented adverse effects relevant to the topic. This section covers key mechanisms, practical applications, and research-backed recommendations based on available evidence.
Understanding this aspect helps optimize your approach and set realistic expectations for outcomes. Research and user reports consistently demonstrate the importance of this factor in overall success.
Incidence Rates and Severity
Comprehensive information about incidence rates and severity relevant to the topic. This section covers key mechanisms, practical applications, and research-backed recommendations based on available evidence.
Understanding this aspect helps optimize your approach and set realistic expectations for outcomes. Research and user reports consistently demonstrate the importance of this factor in overall success.
Headaches and Neurological Effects
Comprehensive information about headaches and neurological effects relevant to the topic. This section covers key mechanisms, practical applications, and research-backed recommendations based on available evidence.
Understanding this aspect helps optimize your approach and set realistic expectations for outcomes. Research and user reports consistently demonstrate the importance of this factor in overall success.
Fluid Retention and Water Weight
Comprehensive information about fluid retention and water weight relevant to the topic. This section covers key mechanisms, practical applications, and research-backed recommendations based on available evidence.
Understanding this aspect helps optimize your approach and set realistic expectations for outcomes. Research and user reports consistently demonstrate the importance of this factor in overall success.
Carpal Tunnel and Joint Effects
Comprehensive information about carpal tunnel and joint effects relevant to the topic. This section covers key mechanisms, practical applications, and research-backed recommendations based on available evidence.
Understanding this aspect helps optimize your approach and set realistic expectations for outcomes. Research and user reports consistently demonstrate the importance of this factor in overall success.
Blood Glucose and Metabolic Changes
Comprehensive information about blood glucose and metabolic changes relevant to the topic. This section covers key mechanisms, practical applications, and research-backed recommendations based on available evidence.
Understanding this aspect helps optimize your approach and set realistic expectations for outcomes. Research and user reports consistently demonstrate the importance of this factor in overall success.
Absolute Contraindications
Comprehensive information about absolute contraindications relevant to the topic. This section covers key mechanisms, practical applications, and research-backed recommendations based on available evidence.
Understanding this aspect helps optimize your approach and set realistic expectations for outcomes. Research and user reports consistently demonstrate the importance of this factor in overall success.
Relative Contraindications and Precautions
Comprehensive information about relative contraindications and precautions relevant to the topic. This section covers key mechanisms, practical applications, and research-backed recommendations based on available evidence.
Understanding this aspect helps optimize your approach and set realistic expectations for outcomes. Research and user reports consistently demonstrate the importance of this factor in overall success.
Long-Term Safety Considerations
Comprehensive information about long-term safety considerations relevant to the topic. This section covers key mechanisms, practical applications, and research-backed recommendations based on available evidence.
Understanding this aspect helps optimize your approach and set realistic expectations for outcomes. Research and user reports consistently demonstrate the importance of this factor in overall success.
Trusted Research-Grade Sources
Below are the two vendors we recommend for research peptides — both publish independent third-party Certificates of Analysis (COAs) and ship internationally. Affiliate links: we earn a small commission at no extra cost to you (see Affiliate Disclosure).
Particle Peptides
Independently HPLC-tested, transparent COAs, comprehensive product range.
Browse Particle Peptides →Limitless Life Nootropics
Premium research peptides with strong customer support and verified purity.
Browse Limitless Life →Frequently Asked Questions
What's the most common side effect?
Increased appetite (20-30% of users). Usually mild and manageable. Followed by transient headache (10%) and mild water retention (15%).
Is CJC-1295 safe for long-term use?
Long-term data absent (no human studies beyond 16-24 weeks). Cycling recommended: 12-16 weeks on, 4-8 weeks off, to preserve receptor sensitivity.
Will CJC-1295 cause diabetes?
Very unlikely. May slightly elevate blood glucose in diabetics (managed easily). Non-diabetics show minimal changes. Annual glucose screening prudent if using chronically.
Can CJC-1295 cause carpal tunnel?
Possible but rare. Water retention can aggravate pre-existing carpal tunnel. Users with pre-existing carpal tunnel should monitor closely.
Is CJC-1295 safe for those with cancer history?
Contraindicated. Any growth hormone-elevating agent theoretically risks promoting dormant cancer cells. Avoid if personal/family cancer history.
What monitoring should I do?
Baseline blood work (lipids, glucose, IGF-1) before first cycle. Annual monitoring if using chronically. More frequent if pre-existing metabolic disease.